Advanced Filters
noise
Found 1,595 clinical trials

Finding Immune Nascent Type 1 Diabetes

The goal of this clinical trial is to understand how many individuals who previously participated in the Indiana Biobank will return a type 1 diabetes home screening kit based upon different methods of recruitment communication. The main question it aims to answer is: What form of recruitment communication is most …

1 - 99 years of age All Phase N/A

Diabetes-Centered Evaluation of Revascularization Strategy of Functional and Imaging-CombiNEd State-of-the-Art Percutaneous Coronary Intervention or Coronary-Artery Bypass Grafting in Patients With Diabetes Mellitus and Multivessel Coronary Artery Disease

The objective of this randomized study was to compare outcomes of imaging-and physiology-guided state-of-the-art percutaneous coronary intervention (PCI) to coronary artery bypass grafting (CABG) in patients with diabetes and three-vessel CAD (not involving left main).

20 years of age All Phase N/A

Examining Digital Health Care Delivery Models Through Medicaid Collaborative

The purpose of this study is to examine the intervention effectiveness and dissemination of digital health care delivery models for improving selected health outcomes in the Medicaid population.

18 years of age All Phase N/A
C Carin Andrén Aronsson, PhD

Intensive Dietary and Activity Counselling (IDAC)

The aim of this intervention study is to investigate if a intensive dietary and physical activity counselling during the first two years of life in children with increased (genetically) risk for Type 1 Diabetes (T1D) can promote a healthy beta-cell environment, in order to reduce increased weight gain and development …

3 - 4 years of age All Phase N/A
B Bart Van der Schueren, MD, PhD

Prevalence of Overweight and Obesity in Adult Patients Suffering From Type 1 Diabetes

A registry of individuals with type 1 diabetes that visited the Department of Endocrinology of the University Hospitals of Leuven is established. The objective of this registry is to phenotype patients with type 1 diabetes and obesity and their response to treatment with regard to their outcomes

years of age All Phase N/A
Y Yang Xiao, MD/PhD

Environmental Determinants of Type 1 Diabetes Risk

To analyze the environmental risk factors for type 1 diabetes in China.

3 - 70 years of age All Phase N/A
J JANET K SNELL-BERGEON, PhD

PRenatal and Obstetric Maternal Exposures and ISlet Autoantibodies in Early Life

This research study is called 'PRenatal and Obstetric Maternal Exposures and ISlet Autoantibodies in Early Life: The PROMISE Study'. The purpose of this study is to find out more about how exposures during pregnancy, such as having an infection, diet and growth may impact later risk of type 1 diabetes …

- 99 years of age All Phase N/A
R Ross Tsuyuki, PharmD, MSc

Implementation and Evaluation of a Pharmacist-led Diabetes Care Pathway in Alberta Community Pharmacies

As of 2024, nine percent of Albertans are living with Type 2 diabetes, which increases their risk for cardiovascular disease, stroke, blindness, and kidney failure. Unfortunately, less than half of patients have controlled Type 2 diabetes. We are well aware of the factors which lead to worsening diabetes, but need …

18 years of age All Phase N/A
A Anette-G Ziegler, Prof. Dr.

Anti-viral Action Against Type 1 Diabetes Autoimmunity

The study GPPAD-05 AVAnT1A is a phase 4 clinical trial intending to enroll 2252 children, who will be randomly assigned to receive COVID-19 vaccination (Comirnaty® 3 μg Omicron XBB.1.5 or new variant Comirnaty vaccines ) or placebo from age 6 months. The study is an investigator initiated, randomized, controlled, multicentre, …

3 - 4 years of age All Phase 4
S Sandra Pena, CCRP

TrialNet Pathway to Prevention of T1D

Rationale The accrual of data from the laboratory and from epidemiologic and prevention trials has improved the understanding of the etiology and pathogenesis of type 1 diabetes mellitus (T1DM). Genetic and immunologic factors play a key role in the development of T1DM, and characterization of the early metabolic abnormalities in …

2 - 45 years of age All Phase N/A

Simplify language using AI